EMPACON MET 12.5/1000 TABLETS

Product Description

EMPACON MET 12.5/1000 TABLETS
(Composition: Empagliflozin 12.5 mg + Metformin Hydrochloride IP 1000 mg)

Boost your anti-diabetic portfolio with EMPACON MET 12.5/1000 TABLETSan effective dual-action oral medication designed for the management of type 2 diabetes mellitus.

Key Features & Benefits:

• Dual Mechanism: Combines SGLT2 inhibitor (Empagliflozin) and biguanide (Metformin) for enhanced glycemic control.

• Cardiovascular Benefit: Empagliflozin supports heart health in diabetic patients.

• Improved Glycemic Control: Metformin reduces hepatic glucose production and increases insulin sensitivity.

• High Strength Formulation: Optimized 12.5/1000 mg dose for advanced diabetes therapy.

• Trusted Quality: Manufactured with pharmaceutical-grade excipients and compliance to IP standards.

Indication:
Indicated for adults with type 2 diabetes mellitus to improve glycemic control, particularly in patients unresponsive to monotherapy.

Target Audience:
Ideal for pharmaceutical distributors, wholesalers, diabetic care specialists, and medical retailers seeking high-demand oral hypoglycemic agents in bulk.

Packaging & Supply:
Available in bulk quantities with assured product integrity and regulatory compliance.